NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION
29 April 2019
Micro Focus International plc
Results of General Meeting
Micro Focus International plc ("Micro Focus" or "the Company", LSE: MCRO.L, NYSE: MFGP) is pleased to announce that, at the General Meeting of the Company's shareholders held earlier today, the resolution proposed to approve the B Share Scheme and to amend the Company's articles of association (the "Resolution") was duly passed on a poll vote.
The full text of the Resolution is shown in the notice of the General Meeting set out in the circular sent to Shareholders on 1 April 2019 and full details of the votes received from the Company's shareholders for the Resolution will be available on our website at www.microfocus.com.
A copy of the Resolution will be submitted to the National Storage Mechanism, where it will shortly be available for inspection at http://www.morningstar.co.uk/uk/NSM.
Completion of the B Share Scheme is expected to occur later today. The Share Capital Consolidation is conditional upon Admission and is expected to take effect at 8.00 a.m. (UK time) on 30 April 2019, in respect of the Ordinary Shares and 9.30 a.m. (New York City time) on 30 April 2019 in respect of the ADSs, the Business Day following the redemption of the B Shares.
Application has been made for the admission of 371,641,408 New Ordinary Shares to be listed on the premium listing segment of the Official List of the UK Listing Authority and to be admitted to trading on the Main Market of the London Stock Exchange, comprising 343,275,832 New Ordinary Shares to be listed with voting rights, 19,535,213 New Ordinary Shares that will be held in treasury and a block listing of 8,830,363 New Ordinary Shares to be issued by the Company from time to time.
Undefined capitalised terms have the same meanings as defined in the announcement on 1 April 2019.
For further information, please contact:
This announcement has been issued by and is the sole responsibility of Micro Focus.
This announcement is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities pursuant to this announcement or otherwise.
This announcement has been prepared in accordance with English law, the EU Market Abuse Regulation and the Disclosure Guidance and Transparency Rules of the UKLA and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.
The release, publication or distribution of this announcement in, into or from jurisdictions outside the United Kingdom and the United States may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe such restrictions. Any failure to comply with the restrictions may constitute a violation of the securities law of any such jurisdiction.
About Micro Focus
Micro Focus (LSE: MCRO.L, NYSE: MFGP) is a global enterprise software company supporting the technology needs and challenges of the Global 2000. Our solutions help organizations leverage existing IT investments, enterprise applications and emerging technologies to address complex, rapidly evolving business requirements while protecting corporate information at all times. Our product portfolios are Security, IT Operations Management, Application Delivery Management, Information Management & Governance and Application Modernization & Connectivity. For more information, visit: www.microfocus.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.